BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21055355)

  • 21. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
    Kollara A; Brown TJ
    Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
    Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
    Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice.
    Yin C; Xi L; Wang X; Eapen M; Kukreja RC
    J Mol Cell Cardiol; 2005 Oct; 39(4):681-9. PubMed ID: 16125197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference libraries prove their worth in hunt for tumor suppressor genes.
    Downward J
    Cell; 2005 Jun; 121(6):813-5. PubMed ID: 15960967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POU homeodomain genes and myogenesis.
    Dominov JA; Miller JB
    Dev Genet; 1996; 19(2):108-18. PubMed ID: 8900043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2.
    El Mourabit H; Müller S; Tunggal L; Paulsson M; Aumailley M
    Protein Expr Purif; 2003 Nov; 32(1):95-103. PubMed ID: 14680945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
    Mohankumar KM; Xu XQ; Zhu T; Kannan N; Miller LD; Liu ET; Gluckman PD; Sukumar S; Emerald BS; Lobie PE
    Oncogene; 2007 Jun; 26(27):3998-4008. PubMed ID: 17213808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Construction and identification of a eukaryotic expression vector for the small interfering RNA targeting nucleostemin gene].
    Zhang GY; Zhao GQ; Yin L; Zhang QX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):392-5. PubMed ID: 18359698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
    Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
    Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired intestinal wound healing in Fhl2-deficient mice is due to disturbed collagen metabolism.
    Kirfel J; Pantelis D; Kabba M; Kahl P; Röper A; Kalff JC; Buettner R
    Exp Cell Res; 2008 Dec; 314(20):3684-91. PubMed ID: 18950620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA silencing genes control de novo DNA methylation.
    Chan SW; Zilberman D; Xie Z; Johansen LK; Carrington JC; Jacobsen SE
    Science; 2004 Feb; 303(5662):1336. PubMed ID: 14988555
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients.
    Kato T; Sato N; Takano A; Miyamoto M; Nishimura H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2008 Apr; 14(8):2363-70. PubMed ID: 18413826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47.
    Chan KK; Tsui SK; Ngai SM; Lee SM; Kotaka M; Waye MM; Lee CY; Fung KP
    J Cell Biochem; 2000 Jan; 76(3):499-508. PubMed ID: 10649446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
    Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
    EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Mitf by small interfering RNA induces dedifferentiation of chick embryonic retinal pigment epithelium.
    Iwakiri R; Kobayashi K; Okinami S; Kobayashi H
    Exp Eye Res; 2005 Jul; 81(1):15-21. PubMed ID: 15978250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.
    Navakanit R; Graidist P; Leeanansaksiri W; Dechsukum C
    J Med Assoc Thai; 2007 Nov; 90(11):2416-21. PubMed ID: 18181329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney.
    Hassan A; Tian Y; Zheng W; Ji H; Sandberg K; Verbalis JG
    Physiol Genomics; 2005 May; 21(3):382-8. PubMed ID: 15784697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.